Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients

Background: Severe pneumonia and acute respiratory distress syndrome (ARDS) due to COVID-19 is a challenge for nowadays medical practice. Although there is no clarity in the principal mechanism of lung damage and ARDS development, it has been suggested that one of the main reasons of this pathology...

Descripción completa

Detalles Bibliográficos
Autores principales: Cala-García, Juan David, Sierra-Bretón, Juan David, Cavelier-Baiz, Jorge Eduardo, Faccini-Martínez, Álvaro A, Pérez-Díaz, Carlos Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363061/
https://www.ncbi.nlm.nih.gov/pubmed/32664810
http://dx.doi.org/10.2217/imt-2020-0154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363061/
https://www.ncbi.nlm.nih.gov/pubmed/32664810
http://dx.doi.org/10.2217/imt-2020-0154

Ejemplares similares